UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000046940
Receipt number R000053557
Scientific Title A Study on the Effect of Food Containing Plant Extract on Capillary blood flow-Open Study -
Date of disclosure of the study information 2022/02/18
Last modified on 2023/06/14 16:46:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Study on the Effect of Food Containing Plant Extract on Capillary blood flow-Open Study -

Acronym

A Study on the Effect of Food Containing Plant Extract on Capillary blood flow

Scientific Title

A Study on the Effect of Food Containing Plant Extract on Capillary blood flow-Open Study -

Scientific Title:Acronym

A Study on the Effect of Food Containing Plant Extract on Capillary blood flow

Region

Japan


Condition

Condition

No

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To confirm the effect of food containing plant extract on capillary blood flow

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Status of capillary

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Food containing plant extract, 8 weeks consumption

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

59 years-old >=

Gender

Female

Key inclusion criteria

(1) Healthy females aged 40 to 59 years-old.
(2) Subjects who aware of coldness.
(3) Subjects who can make self-judgment and are voluntarily giving written informed consent.

Key exclusion criteria

(1) Subjects who were diagnosed with serious disease (e.g., diabetes, liver disease, kidney disease, digestive disease, heart disease, respiratory disease and/or peripheral vascular disease).
(2) Subjects who had a gastrointestinal surgery.
(3) Subjects with strange finger conditions at measurement points.
(4) Subjects with a disease currently under treatment.
(5) Subjects with drug or food allergies.
(6) Subjects with anemic.
(7) Women who are/might be pregnant or lactating during the current study periods.
(8) Subjects who play high intensity sports and/or are on a diet.
(9) Subjects who have an extremely irregular eating habit.
(10) Subjects who can't stop using functional foods (including Food for Specified Health Uses or Foods with Function Claims) and/or Specified quasi-drugs during the current study periods.
(11) Subjects who have alcohol intake more than average 60 g/day of pure alcohol equivalent.
(12) Subjects who smoke an average of 21 or more cigarettes in a day
(13) Subjects who can't stop their manicure or false nail during the current study periods.
(14) Subjects who are participating in other studies or planning to participate at the start of the current study.
(15) Subjects who are judged as unsuitable for the current study by the investigator for other reasons.

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Naoki
Middle name
Last name Miura

Organization

Miura Clinic, Medical Corporation Kanonkai

Division name

Internal Medicine

Zip code

530-0044

Address

Higashitenma building 9F, 1-7-17, Higashitenma, Kita-ku, Osaka, Osaka

TEL

06-6135-5200

Email

mterashima@miula.co.jp


Public contact

Name of contact person

1st name Makoto
Middle name
Last name Terashima

Organization

Oneness support Co., Ltd.

Division name

Clinical trial Division

Zip code

530-0044

Address

Higashitenma building 4F, 1-7-17, Higashitenma, Kita-ku, Osaka, Osaka

TEL

06-4801-8917

Homepage URL


Email

mterashima@oneness-sup.co.jp


Sponsor or person

Institute

Oneness support Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

TOYO SHINYAKU Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Ethics Committee of Miura Clinic, Medical Corporation Kanonkai

Address

Higashitenma building 9F, 1-7-17, Higashitenma, Kita-ku, Osaka, Osaka

Tel

06-6135-5200

Email

mterashima@miula.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 02 Month 18 Day


Related information

URL releasing protocol

https://center6.umin.ac.jp/cgi-bin/ctr/ctr_view_reg.cgi?recptno=R000053557

Publication of results

Published


Result

URL related to results and publications

http://www.pieronline.jp/content/article/0386-3603/51010/129

Number of participants that the trial has enrolled

10

Results

Statistically significant difference was confirmed in the primary outcome.

Results date posted

2023 Year 06 Month 14 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Females aged 40 to 59 years old.

Participant flow

Enrolled(n=10)
Completed(n=10)
Analysed(n=9)

Adverse events

No adverse events were observed that be related to test food.

Outcome measures

Status of capillary

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2022 Year 02 Month 14 Day

Date of IRB

2022 Year 02 Month 17 Day

Anticipated trial start date

2022 Year 02 Month 21 Day

Last follow-up date

2022 Year 05 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 02 Month 18 Day

Last modified on

2023 Year 06 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053557